ACAD
HEALTHCAREAcadia Pharmaceuticals Inc
$21.48-0.87 (-3.89%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving ACAD Today?
No stock-specific AI insight has been generated for ACAD yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$16.76$28.35
$21.48
Fundamentals
Market Cap$3.8B
P/E Ratio9.7
EPS$2.30
Dividend Yield—
Dividend / Share—
ROE0.4%
Profit Margin0.4%
Debt / Equity—
Trading
Volume3.6M
Avg Volume (10D)—
Shares Outstanding171.2M
ACAD News
20 articles- What ACADIA Pharmaceuticals (ACAD)'s Earnings Miss, EU Setback and R&D Transition Means For ShareholdersYahoo Finance·May 9, 2026
- ACAD Q1 Earnings & Revenues Miss Estimates Despite Y/Y Sales GrowthYahoo Finance·May 7, 2026
- ACADIA Pharmaceuticals Q1 Earnings Call HighlightsMarketbeat·May 6, 2026
- Acadia (ACAD) Q1 2026 Earnings TranscriptMotley Fool·May 6, 2026
- Acadia Pharmaceuticals (ACAD) Lags Q1 Earnings and Revenue EstimatesYahoo Finance·May 6, 2026
- Acadia Pharmaceuticals Reports First Quarter 2026 Financial Results and Reaffirms 2026 Financial GuidanceYahoo Finance·May 6, 2026
- ImmunityBio to Report Q1 Earnings: What's in the Cards?Yahoo Finance·May 4, 2026
- ACADIA (ACAD) Upgraded to Buy After Recent PullbackYahoo Finance·May 2, 2026
- Acadia Pharmaceuticals Announces Planned Year-End Retirement of Elizabeth H.Z. Thompson, Ph.D., Head of Research and Development, Following a Distinguished CareerYahoo Finance·Apr 30, 2026
- CSLLY vs. ACAD: Which Stock Is the Better Value Option?Yahoo Finance·Apr 30, 2026
- Iovance Biotherapeutics (IOVA) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseYahoo Finance·Apr 30, 2026
- Acadia Pharmaceuticals (ACAD) Expected to Beat Earnings Estimates: Should You Buy?Yahoo Finance·Apr 29, 2026
- Acadia Pharmaceuticals to Participate at Upcoming Investor ConferencesYahoo Finance·Apr 28, 2026
- ACADIA Pharmaceuticals Inc. (ACAD) PT Trimmed Slightly as RBC Flags Seasonal Biotech HeadwindsYahoo Finance·Apr 24, 2026
- Acadia Pharmaceuticals to Present Data at the 2026 American Academy of Neurology (AAN) Annual MeetingYahoo Finance·Apr 17, 2026
- How Investors Are Reacting To ACADIA Pharmaceuticals (ACAD) Expanding DAYBUE STIX Access for Rett SyndromeYahoo Finance·Apr 15, 2026
- Acadia Pharmaceuticals to Announce First Quarter 2026 Financial Results on May 6, 2026Yahoo Finance·Apr 15, 2026
- Acadia (ACHC) Q3 2025 Earnings Call TranscriptMotley Fool·Apr 14, 2026
- CSLLY vs. ACAD: Which Stock Should Value Investors Buy Now?Yahoo Finance·Apr 14, 2026
- Will Acadia (ACAD) Beat Estimates Again in Its Next Earnings Report?Yahoo Finance·Apr 8, 2026
All 20 articles loaded
Price Data
Open$22.54
Previous Close$22.35
Day High$23.07
Day Low$21.36
52 Week High$28.35
52 Week Low$16.76
52-Week Range
$16.76$28.35
$21.48
Fundamentals
Market Cap$3.8B
P/E Ratio9.7
EPS$2.30
Dividend Yield—
Dividend / Share—
ROE0.4%
Profit Margin0.4%
Debt / Equity—
Trading
Volume3.6M
Avg Volume (10D)—
Shares Outstanding171.2M
About Acadia Pharmaceuticals Inc
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company is headquartered in San Diego, California.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—